Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 04, 2022 09:21 ET | Source: Spectral Medical Inc.

Spectral Medical Provides Update on Tigris Clinical Trial

Robust recruitment activities experienced in closing weeks of September44 patients now enrolled TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
August 18, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces FDA Approval to Add Up to 10 Additional Tigris Clinical Trial Sites

TORONTO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
August 12, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces Second Quarter Results and Provides Corporate Update

TORONTO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
August 08, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical and Distribution Partner Marathon Medical Awarded Contract to Provide SAMI Dialysis Devices to the US Department of Veterans Affairs

TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
July 26, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical’s Chief Medical Officer, Dr. John Kellum, to be the Featured Speaker in Webinar Hosted by Sepsis Alliance

TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
July 20, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Provides Update on Tigris Clinical Trial

Provides positive case study on patient enrolled at University of Michigan 14 clinical sites actively enrolling patients with 40 patients now randomized TORONTO, July 20, 2022 (GLOBE NEWSWIRE) --...
July 14, 2022 10:00 ET | Source: Spectral Medical Inc.

Spectral Medical Highlights From Vicenza Course 2022

TORONTO, July 14, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
July 13, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022

TORONTO, July 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
July 11, 2022 08:00 ET | Source: Spectral Medical Inc.

US FDA Grants Spectral Medical Breakthrough Device Designation for Toraymyxin™ (“PMX”) for the Treatment of Endotoxemic Septic Shock

TORONTO, July 11, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
June 21, 2022 16:20 ET | Source: Spectral Medical Inc.

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...